ZEAL — Zealand Pharma A/S Share News
0.000.00%
Last trade - 00:00- DKK20.13bn
- DKK6.08bn
- DKK9.21bn
Brief: Zealand Scraps Potential Obesity Drug, Citing Crowded Market - Bloomberg News
Brief: Zealand Pharma Q3 Operating Loss DKK 461.3 Million
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Pharma companies announce direct-to-consumer sales and price cuts in US
Zealand Pharma slumps, analysts point to rival trial data
Lilly moves obesity drug to late-stage trials after it shows promise (updated)
Factbox: Who's on Novo Nordisk's board after major shakeup?
Factbox: Pharma companies announce direct-to-consumer sales and price cuts in US
Novo Nordisk shares fall 5.6% after Trump vows weight-loss drug price cut (updated)
Factbox: Pharma companies announce direct-to-consumer sales and price cuts in US
Novo Nordisk shares fall on 'costly' Akero Therapeutics acquisition
Obesity kings’ buffet is slimmer than it looks
Factbox: Big pharma firms announce direct-to-consumer sales and price cuts in U.S.
Refile: BUZZ-'Overall a relief': TrumpRx price cuts deals boost European pharma stocks
European pharma stocks largely steady amid new US tariff onslaught
UBS starts Zealand Pharma with 'buy' on 2026 obesity drug catalysts
Top of the Street: Italgas, Snam, Terna and Zealand Pharma
Zealand Pharma may sell future obesity drug direct to patients (updated)
Zealand Pharma may sell future obesity drug direct to patients, amid market shifts